Technology · Biotechnology R&D expenditure

Biotechnology R&D expenditure in China in 2026

In 2026, China's reported biotechnology R&D expenditure was 30 B $, ranking 1 out of 197 nations. This figure, however, is misleading: China is among the top three global investors in biotech, second only to the United States. Massive funding flows into genomics, gene editing, and biopharmaceuticals, particularly in hubs like Shanghai, Shenzhen, and Beijing. The zero value likely stems from reporting methodologies that exclude state-led R&D programs from market-based statistics.

Data for 2026 · unit: $
Position

China world ranking

#1 / 197

Country position on the scale from last to first place for this indicator.

CN
#1
#197#1
Trend

Change over time

Change in indicator over the available period.

50 M
1990
500 M
2000
5 B
2010
25 B
2020
30 B
2025
30 B
2026

Values — $

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Biotechnology R&D expenditure in China — how much?
Based on 2026 data — 30 B $. This is rank #1 out of 197 countries.
What is China's rank by Biotechnology R&D expenditure?
China ranks #1 out of 197 countries in the world ranking by «Biotechnology R&D expenditure».
How has Biotechnology R&D expenditure changed in China?
Over the available period the indicator changed from 50 M to 30 B $.